What Are RNP Granules? Their Role in Health and Disease

Ribonucleoprotein (RNP) granules are compartments inside cells that form without a surrounding membrane, assembling instead from clusters of RNA molecules and the proteins that bind them.¹ Every cell in your body contains them, and they show up in organisms from bacteria to mammals.² When working correctly, these granules help cells manage stress, control which proteins get made, and ferry molecular cargo to distant corners of a neuron. When their behavior goes off the rails, they are increasingly linked to neurodegenerative diseases, cancer drug resistance, and the general decline of cellular housekeeping that comes with aging.

How Cells Build Compartments Without Walls

Most organelles you hear about in biology, like the nucleus or mitochondria, are enclosed by lipid membranes that physically separate their contents from the rest of the cell. RNP granules skip that step entirely. They form through a process often compared to oil droplets separating from vinegar in a salad dressing: molecules that prefer each other’s company concentrate together and spontaneously separate from the surrounding liquid. Biologists call this liquid-liquid phase separation.³

The key players driving this separation are RNA-binding proteins that contain floppy, unstructured stretches rather than rigid shapes. These disordered regions stick to each other through many weak, overlapping contacts, and when RNA is present, the tendency to cluster together gets even stronger.⁴ The result is a liquid droplet that can form in seconds, exchange its contents with the surrounding cell fluid, and dissolve just as quickly when conditions change. That reversibility is the whole point: the cell gets a temporary compartment that concentrates specific molecules when needed and vanishes when the job is done.

The Major Types You Encounter in a Cell

RNP granules are not a single thing. They come in several flavors, each with a different job and a different mix of components. The two most heavily studied types in the cytoplasm are stress granules and processing bodies, but granules also appear in neurons, in the germline cells that give rise to eggs and sperm, and inside the nucleus itself.

Stress Granules

When a cell encounters trouble, whether from heat, toxins, starvation, or infection, one of its first moves is to slam the brakes on protein production. The messenger RNA molecules that were being actively translated get stalled, and many of them cluster together with RNA-binding proteins into large, visible clumps called stress granules.⁵ Think of this as a triage system: the cell temporarily shelves most of its protein-making machinery so it can redirect resources toward survival. Once the stress passes, stress granules dissolve and the stored messenger RNAs return to work.⁶

Processing Bodies

Processing bodies, or P-bodies, are present even under normal conditions, not just during stress. They are enriched in proteins involved in breaking down or silencing messenger RNA, and for years the assumption was that P-bodies were mainly destruction zones where unwanted transcripts got chewed up.⁷ More recent work has complicated that picture. Messenger RNAs sitting inside a P-body are not necessarily doomed; they can be stored there and later returned to active translation.⁸ P-bodies and stress granules share some protein components, can physically touch each other, and sometimes even form hybrid structures, suggesting the two granule types are not as separate as their names imply.⁹

Neuronal and Germ Granules

Neurons face a unique logistical challenge: their axons and dendrites can extend enormous distances from the cell body where most messenger RNA is made. Neuronal RNP granules package messenger RNAs and shuttle them along these extensions, hitching rides on membrane-bound transport vesicles to reach distant sites where local protein production is needed.¹⁰ This local translation is critical for processes like strengthening or weakening the connections between neurons, which underpins learning and memory.¹¹

Germ granules, found in reproductive cells, serve a different purpose. In organisms from worms to mammals, these granules regulate which messenger RNAs are translated in the germline and help maintain the identity of reproductive cells across generations.¹² They influence small RNA production, control mRNA abundance, and even contribute to what gets inherited through the cytoplasm of the egg cell rather than through DNA. The germline, in other words, relies on RNP granules not just for day-to-day housekeeping but for continuity between generations.

How Cells Keep Granules Under Control

Because granules form through a delicate balance of weak molecular interactions, cells have developed multiple ways to tune that balance. One of the most important is chemical modification of the proteins involved. Small chemical tags added to or removed from RNA-binding proteins can either strengthen or weaken the interactions that drive phase separation, acting like a dimmer switch on granule formation.¹³ Phosphorylation, methylation, and other modifications give the cell precise control over when and where granules appear.

Equally important is the disassembly side. After stress subsides, stress granules need to be cleared efficiently. An enzyme called VCP plays a central role in this cleanup, and recent work has identified a partner protein called ASPL that coordinates the assembly and disassembly processes, essentially linking the on switch and the off switch so the cell doesn’t lose track of its granules.¹⁴ When either the formation or the clearance machinery breaks down, granules can persist far longer than they should, and that persistence is where disease often enters the picture.

When Granules Turn Toxic in Neurodegeneration

The connection between RNP granules and neurodegenerative disease is one of the most active areas in the field right now. Two diseases in particular, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), are deeply intertwined with granule biology because several of the proteins most commonly mutated in these diseases are themselves core components of RNP granules.¹⁵

The proteins TDP-43 and FUS are normally involved in RNA processing and appear in stress granules during cellular stress. Mutations in either protein change the way granules behave. Disease-linked mutations in FUS, for instance, favor transitions from a normally fluid, liquid-like droplet state into a more rigid, solid-like state, producing aggregates that the cell cannot dissolve.¹⁶ Cells expressing ALS-linked TDP-43 mutations form more stress granules, and those granules are larger than normal; mutant FUS similarly increases both the proportion of cells that form granules under stress and the size of individual granules.¹⁷

TDP-43 also appears to be necessary for a normal maturation step in stress granules. In motor and cortical neurons, stress granules usually grow over time as smaller granules fuse into larger ones. When researchers depleted TDP-43 from these neurons, that coalescence stopped: granule size and number remained static instead of shifting as expected.¹⁸ So TDP-43 is not merely a passive passenger in granules; it actively shapes how they evolve. When mutations cause it to malfunction, the normal dynamic cycle of formation, maturation, and clearance breaks down.

A separate genetic cause of ALS involves a repeat expansion in the C9orf72 gene, the most common inherited form of both ALS and FTD. This mutation produces abnormal dipeptide repeat proteins that can bind a key stress granule scaffolding protein called G3BP1 roughly a thousand times more strongly than RNA does, hijacking the granule assembly process.¹⁹ The resulting droplets slowly harden into aggregated states that recruit other ALS-linked proteins like TDP-43 and hnRNPA1 into the mess. These same dipeptide repeats have been shown to alter the material properties of multiple membrane-less organelles, disrupting their normal dynamics and functions throughout the cell.²⁰

Cancer Cells Exploit Stress Granules to Survive Treatment

The relationship between RNP granules and cancer is different from the neurodegeneration story. In neurodegenerative disease, the problem is that granules solidify and become toxic. In cancer, the problem is that granules work too well. Cancer cells are under constant stress from nutrient deprivation, low oxygen, and, during treatment, chemotherapy drugs. Stress granules help cells ride out exactly these kinds of insults by temporarily shelving protein production and protecting messenger RNAs that the cell will need once conditions improve.

Cancer cells appear to have an enhanced ability to form stress granules compared to normal cells, and they rely more heavily on those granules to survive adverse conditions.²¹ This is a significant problem for treatment. When chemotherapy drugs trigger stress granule formation, the granules help tumor cells dodge the death signals that the drugs are designed to deliver, contributing to drug resistance.²² The granules also allow cancer cells to reprogram their metabolism and modulate immune responses in the surrounding tissue.²³

This realization has researchers looking at stress granule inhibition as a possible way to make existing cancer therapies more effective. If you could prevent tumor cells from forming protective granules during chemotherapy, the drugs might kill more cancer cells. The challenge is that stress granules are also important for healthy cells under stress, so any therapeutic approach would need to target the cancer-specific features of granule formation rather than shutting down the process entirely.

Viruses and the Battle Over Granule Formation

The stress granule machinery also sits at a crossroads of the immune response to viral infection. When a cell detects viral RNA, one of its defensive reactions is to shut down protein synthesis and assemble stress granules, which can serve as platforms for activating antiviral signaling pathways. Some viruses, in response, have evolved ways to actively block stress granule formation, essentially disarming that arm of the cell’s defense.²⁴

Other viruses take the opposite approach and appear to co-opt granule-like structures for their own replication. The same phase-separation machinery that builds stress granules can be redirected by viral proteins to create compartments that concentrate viral RNA and replication factors, shielding the virus from cellular defenses. This tug-of-war over granule formation has made RNP granules an interesting lens through which to study host-pathogen interactions, and possibly an angle for antiviral drug development.

Aging and the Slow Failure of Granule Cleanup

Even in the absence of a disease-causing mutation, the simple passage of time degrades a cell’s ability to manage its RNP granules. Young, healthy cells have robust quality-control systems, including protein-degradation pathways and autophagy, that efficiently clear stress granules once the triggering stress is gone. As cells age, these cleanup systems weaken. The result is that granules persist longer than they should after stress, and that lingering gives their contents more opportunity to transition from a fluid, reversible state into solid, irreversible aggregates.²⁵

Aging neurons are particularly vulnerable. They show an increased tendency to form stress granules while simultaneously losing efficiency in clearing them, a combination that promotes the accumulation of pathological protein aggregates like TDP-43 and tau.²⁶ This creates a feedback loop: persistent granules seed more aggregation, and accumulated aggregates further burden the already-declining cleanup machinery. The overlap between normal aging and neurodegenerative disease in this regard is striking and suggests that age-related decline in granule management may be one reason why diseases like ALS and Alzheimer’s are diseases of older adults rather than conditions that strike at any age.

Early Therapeutic Efforts

Given how central RNP granule dysfunction appears to be in both neurodegeneration and cancer, researchers are starting to look for ways to intervene pharmacologically. One line of work has identified a small molecule called lipoamide that can specifically prevent the abnormal cytoplasmic condensation of stress granule proteins, and experiments in ALS models suggest this approach has therapeutic potential.²⁷ Lipoamide works through a redox mechanism, essentially changing the chemical environment in a way that disfavors the aggregation of granule components. It is still far from clinical use, but it represents a proof of concept that granule behavior can be modulated from outside the cell.

Meanwhile, new research tools are giving scientists far more precise control over granule biology in living cells. Optogenetic approaches, which use light-sensitive protein domains fused to disease-associated granule proteins, allow researchers to trigger or reverse condensate formation with precise spatial and temporal control.²⁸ By flipping granule assembly on and off with a pulse of light, researchers can study exactly when and where in the disease process granule formation becomes harmful, knowledge that is essential for designing therapies that hit the right stage of the problem.

An Ancient Organizing Principle

One of the more striking realizations in this field is how old the underlying mechanism is. Biomolecular condensates formed by phase separation are not a recent evolutionary invention of complex organisms. They appear across the tree of life, from bacteria to mammals, and they may trace back to the earliest stages of life on Earth.²⁹ Before cells had membranes to create compartments, phase-separated droplets of molecules in primordial pools could have served as primitive reaction chambers, concentrating the right ingredients for early biochemical processes. If that hypothesis holds up, the same physical principle that causes trouble in ALS and drug-resistant tumors was a precondition for life getting started in the first place.

Condensates were long assumed to be a eukaryotic innovation, something that evolved only in cells with nuclei and complex internal organization. That assumption has been overturned. Bacteria and other microbes use phase-separated compartments for a variety of functions, and the physical principles driving condensate formation are conserved across diverse microbial lineages.³⁰ This universality suggests that the ability to create temporary, membrane-free compartments conferred such a strong advantage that evolution preserved it over billions of years, even as organisms developed far more sophisticated ways of organizing their internal space.